001     155830
005     20231218101804.0
024 7 _ |a 10.1038/s41593-020-00758-5
|2 doi
024 7 _ |a pmid:33257876
|2 pmid
024 7 _ |a 1097-6256
|2 ISSN
024 7 _ |a 1546-1726
|2 ISSN
024 7 _ |a altmetric:95197177
|2 altmetric
037 _ _ |a DZNE-2021-00990
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Meinhardt, Jenny
|b 0
245 _ _ |a Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19.
260 _ _ |a New York, NY
|c 2021
|b Nature America
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1702891026_15629
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The newly identified severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19, a pandemic respiratory disease. Moreover, thromboembolic events throughout the body, including in the CNS, have been described. Given the neurological symptoms observed in a large majority of individuals with COVID-19, SARS-CoV-2 penetrance of the CNS is likely. By various means, we demonstrate the presence of SARS-CoV-2 RNA and protein in anatomically distinct regions of the nasopharynx and brain. Furthermore, we describe the morphological changes associated with infection such as thromboembolic ischemic infarction of the CNS and present evidence of SARS-CoV-2 neurotropism. SARS-CoV-2 can enter the nervous system by crossing the neural-mucosal interface in olfactory mucosa, exploiting the close vicinity of olfactory mucosal, endothelial and nervous tissue, including delicate olfactory and sensory nerve endings. Subsequently, SARS-CoV-2 appears to follow neuroanatomical structures, penetrating defined neuroanatomical areas including the primary respiratory and cardiovascular control center in the medulla oblongata.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a RNA, Viral
|2 NLM Chemicals
650 _ 2 |a Brain: virology
|2 MeSH
650 _ 2 |a COVID-19: virology
|2 MeSH
650 _ 2 |a Central Nervous System
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Olfactory Mucosa: virology
|2 MeSH
650 _ 2 |a RNA, Viral: genetics
|2 MeSH
650 _ 2 |a SARS-CoV-2: pathogenicity
|2 MeSH
650 _ 2 |a Smell: physiology
|2 MeSH
650 _ 2 |a Virus Internalization
|2 MeSH
700 1 _ |a Radke, Josefine
|0 0000-0001-9860-2007
|b 1
700 1 _ |a Dittmayer, Carsten
|b 2
700 1 _ |a Franz, Jonas
|0 0000-0001-7523-6622
|b 3
700 1 _ |a Thomas, Carolina
|0 0000-0002-7386-1181
|b 4
700 1 _ |a Mothes, Ronja
|b 5
700 1 _ |a Laue, Michael
|b 6
700 1 _ |a Schneider, Julia
|0 0000-0002-0494-1022
|b 7
700 1 _ |a Brünink, Sebastian
|b 8
700 1 _ |a Greuel, Selina
|b 9
700 1 _ |a Lehmann, Malte
|b 10
700 1 _ |a Hassan, Olga
|b 11
700 1 _ |a Aschman, Tom
|b 12
700 1 _ |a Schumann, Elisa
|b 13
700 1 _ |a Chua, Robert Lorenz
|0 0000-0001-5945-9957
|b 14
700 1 _ |a Conrad, Christian
|b 15
700 1 _ |a Eils, Roland
|0 0000-0002-0034-4036
|b 16
700 1 _ |a Stenzel, Werner
|b 17
700 1 _ |a Windgassen, Marc
|b 18
700 1 _ |a Rößler, Larissa
|b 19
700 1 _ |a Goebel, Hans-Hilmar
|b 20
700 1 _ |a Gelderblom, Hans R
|b 21
700 1 _ |a Martin, Hubert
|b 22
700 1 _ |a Nitsche, Andreas
|b 23
700 1 _ |a Schulz-Schaeffer, Walter J
|b 24
700 1 _ |a Hakroush, Samy
|b 25
700 1 _ |a Winkler, Martin S
|b 26
700 1 _ |a Tampe, Björn
|0 0000-0002-4357-9863
|b 27
700 1 _ |a Scheibe, Franziska
|0 P:(DE-2719)9000850
|b 28
|u dzne
700 1 _ |a Körtvélyessy, Péter
|0 P:(DE-2719)2812030
|b 29
|u dzne
700 1 _ |a Reinhold, Dirk
|b 30
700 1 _ |a Siegmund, Britta
|0 0000-0002-0055-958X
|b 31
700 1 _ |a Kühl, Anja A
|b 32
700 1 _ |a Elezkurtaj, Sefer
|b 33
700 1 _ |a Horst, David
|b 34
700 1 _ |a Oesterhelweg, Lars
|b 35
700 1 _ |a Tsokos, Michael
|b 36
700 1 _ |a Ingold-Heppner, Barbara
|b 37
700 1 _ |a Stadelmann, Christine
|0 P:(DE-2719)9000922
|b 38
|u dzne
700 1 _ |a Drosten, Christian
|b 39
700 1 _ |a Corman, Victor
|0 P:(DE-2719)9001090
|b 40
|u dzne
700 1 _ |a Radbruch, Helena
|b 41
700 1 _ |a Heppner, Frank
|0 P:(DE-2719)2812386
|b 42
|e Last author
|u dzne
773 _ _ |a 10.1038/s41593-020-00758-5
|g Vol. 24, no. 2, p. 168 - 175
|0 PERI:(DE-600)1494955-6
|n 2
|p 168 - 175
|t Nature neuroscience
|v 24
|y 2021
|x 1546-1726
856 4 _ |u https://pub.dzne.de/record/155830/files/DZNE-2021-00990_Restricted.pdf
856 4 _ |u https://pub.dzne.de/record/155830/files/DZNE-2021-00990_Restricted.pdf?subformat=pdfa
|x pdfa
909 C O |p VDB
|o oai:pub.dzne.de:155830
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 28
|6 P:(DE-2719)9000850
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 29
|6 P:(DE-2719)2812030
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 38
|6 P:(DE-2719)9000922
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 40
|6 P:(DE-2719)9001090
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 42
|6 P:(DE-2719)2812386
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2021
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-01-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-01-30
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-01-30
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2022-11-12
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NAT NEUROSCI : 2021
|d 2022-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2022-11-12
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2022-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-12
915 _ _ |a IF >= 25
|0 StatID:(DE-HGF)9925
|2 StatID
|b NAT NEUROSCI : 2021
|d 2022-11-12
920 1 _ |0 I:(DE-2719)1810007
|k AG Heppner
|l Neuroimmunology
|x 0
920 1 _ |0 I:(DE-2719)5000006
|k AG Düzel
|l Clinical Neurophysiology and Memory
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1810007
980 _ _ |a I:(DE-2719)5000006
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21